# OnCo record paper-chesney-j-clin-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-chesney-j-clin-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-chesney-j-clin-oncol" ;
  schema:name "Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma"@en ;
  schema:description "Paper cited by one pairing page, indexed on Europe PMC as PubMed record 35998300 and published in Journal of Clinical Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-chesney-j-clin-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.22.00343>, <https://pubmed.ncbi.nlm.nih.gov/35998300/>, <https://europepmc.org/article/MED/35998300> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.22.00343> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Chesney JA, Ribas A, Long GV, et al." ;
  onco:related <https://onco.cc/pairings/oncolytic-plus-pd1/> ;
  onco:journals <https://onco.cc/journals/jco/> .